GEHCNasdaqX-Ray Apparatus & Tubes & Related Irradiation ApparatusFiscal year ends December 31
GE HealthCare Technologies Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026
$69.76+0.19 (+0.27%)
Close on Oct 19, 2026
- Market cap
- $31.67B
- P/E (TTM)
- 16.0
- Dividend yield
- 0.20%
GE HealthCare Technologies statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of X-Ray Apparatus & Tubes & Related Irradiation Apparatus companies for comparison
Valuation
| Measure | GE HealthCare Technologies | Industry median |
|---|---|---|
| Market Cap | $31.51B | $230.55M |
| Enterprise Value | $39.54B | $202.97M |
| PE Ratio | 16.00 | 31.60 |
| PS Ratio | 1.48 | 3.10 |
| PB Ratio | 2.87 | 3.04 |
| P/FCF Ratio | 19.96 | 27.30 |
| P/OCF Ratio | 15.00 | 22.47 |
Enterprise value
| Measure | GE HealthCare Technologies | Industry median |
|---|---|---|
| EV / Sales | 1.86 | 2.91 |
| EV / EBITDA | 14.46 | 19.74 |
| EV / EBIT | 14.46 | 24.80 |
| EV / FCF | 25.04 | 27.89 |
Income (trailing twelve months)
| Measure | GE HealthCare Technologies | Industry median |
|---|---|---|
| Revenue | $21.27B | $102.39M |
| Gross Profit | $8.41B | $60.36M |
| Operating Income | $2.73B | -$4.31M |
| Pretax Income | $2.66B | -$2.37M |
| Net Income | $1.99B | -$6.57M |
| EBITDA | $2.73B | -$1.98M |
| EPS (Diluted) | $4.36 | -$0.08 |
Margins
| Measure | GE HealthCare Technologies | Industry median |
|---|---|---|
| Gross Margin | 39.5% | 55.2% |
| Operating Margin | 12.9% | -6.04% |
| Pretax Margin | 12.5% | -4.11% |
| Profit Margin | 9.33% | -10.5% |
| EBITDA Margin | 12.9% | -2.67% |
| FCF Margin | 7.42% | 0.02% |
Returns
| Measure | GE HealthCare Technologies | Industry median |
|---|---|---|
| Return on Equity (ROE) | 19.2% | -18.2% |
| Return on Assets (ROA) | 5.46% | -13.3% |
| Return on Invested Capital (ROIC) | 11.3% | -3.69% |
| Return on Capital Employed (ROCE) | 9.45% | -9.07% |
Growth
| Measure | GE HealthCare Technologies | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 6.52% | 8.85% |
| Net Income Growth (YoY) | -11.4% | 10.5% |
| EPS Growth (YoY) | -10.7% | 10.6% |
| FCF Growth (YoY) | 0.64% | 9.68% |
| Revenue Growth (3Y CAGR) | 3.99% | 7.08% |
| EPS Growth (3Y CAGR) | 2.54% | 3.11% |
Balance sheet
| Measure | GE HealthCare Technologies | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $2.08B | $36.66M |
| Total Debt | $10.10B | $97.65M |
| Net Cash (Debt) | -$8.02B | $3.92M |
| Net Cash Per Share | -$17.75 | $0.28 |
| Equity (Book Value) | $10.98B | $55.33M |
| Book Value Per Share | $24.30 | $2.87 |
| Tangible Book Value | -$6.01B | $10.79M |
| Working Capital | $2.20B | $56.72M |
Financial position
| Measure | GE HealthCare Technologies | Industry median |
|---|---|---|
| Current Ratio | 1.26 | 2.48 |
| Quick Ratio | 0.25 | 1.53 |
| Debt / Equity | 0.92 | 0.41 |
| Debt / EBITDA | 3.69 | 2.40 |
| Debt / FCF | 6.39 | 3.49 |
| Net Debt / EBITDA | 2.93 | 1.53 |
Cash flow (trailing twelve months)
| Measure | GE HealthCare Technologies | Industry median |
|---|---|---|
| Operating Cash Flow | $2.10B | -$566.22K |
| Capital Expenditures | -$522.00M | -$3.69M |
| Free Cash Flow | $1.58B | -$696.00K |
| FCF Per Share | $3.50 | -$0.02 |
Efficiency
| Measure | GE HealthCare Technologies | Industry median |
|---|---|---|
| Asset Turnover | 0.58 | 0.58 |
| Inventory Turnover | 5.40 | 2.21 |
| Revenue Per Employee | $393.83K | $322.92K |
| Profits Per Employee | $36.76K | -$51.88K |
| Employee Count | 54,000 | 185 |
Dividends and yields
| Measure | GE HealthCare Technologies | Industry median |
|---|---|---|
| Earnings Yield | 6.30% | -6.88% |
| FCF Yield | 5.01% | -0.45% |
| Dividend Yield | 0.20% | 0.81% |
| Buyback Yield | 1.27% | 0.78% |
| Shareholder Yield | 1.47% | 0.80% |
| Dividend Per Share | $0.14 | $0.72 |
| Dividend Growth (YoY) | 12.0% | 4.80% |
| Years of Dividend Growth | 2 | 0 |
| Payout Ratio | 3.22% | 29.9% |
| FCF Payout Ratio | 4.05% | 21.9% |
Shares
| Measure | GE HealthCare Technologies | Industry median |
|---|---|---|
| Shares Outstanding | 451,686,000 | 44,302,700 |
| Shares Change (YoY) | -0.49% | 3.36% |
| Float | 450,210,000 | 37,462,700 |
| Shares Held by Insiders | 0.33% | 10.5% |
| Shares Held by Institutions | 87.3% | 63.5% |
Taxes
| Measure | GE HealthCare Technologies | Industry median |
|---|---|---|
| Income Tax | $611.00M | $1.52M |
| Effective Tax Rate | 23.0% | 18.5% |
Scores
| Measure | GE HealthCare Technologies | Industry median |
|---|---|---|
| Graham Number | $48.82 | $35.97 |
| Graham Upside | -30.0% | -57.0% |
| Altman Z-Score | 1.84 | 1.95 |
| Piotroski F-Score | 5 | 5 |
Calculated by StockData from GE HealthCare Technologies's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.